T1	Participants 50 95	adults with autistic and Asperger's disorders
T2	Participants 314 393	peptide systems, particularly the oxytocin system, in autism spectrum patients.
T3	Participants 591 635	15 adults with autism or Asperger's disorder
T4	Participants 856 895	Patients with autism spectrum disorders
